[ÀÓ»ó/Á¤±ÔÁ÷] CTM(Clinical Trial Manager/Phase 1 to 3) ¸ðÁý °ø°í
¸ðÁýºÎ¹®
¸ðÁýºÎ¹® ÀÓ»óÆÀ ¸ðÁý±¸ºÐ °æ·Â
¸ðÁýÀοø 0 Çз ´ëÁ¹
Àü°ø ¹× ÀÚ°Ý ¤ýÀ¯°ü°æ·Â 3³â ÀÌ»ó Çʼö
¤ý¾àÇÐ, °£È£ÇÐ, ¼öÀÇÇÐ, »ý¸í°úÇÐ µî °ü·Ã Àü°øÀÚ
¤ý¿µ¾î ¶Ç´Â ÀϺ»¾î °¡´ÉÀÚ ¿ì´ë ±Ù¹«Áö¿ª ¼¿ï º»»ç
¾÷¹«³»¿ë
Phase 1 to 3 Clinical Project Management
- CRO Management
- Site Management
- Communication with Investigators
- Oversight (CRO and Site)
- Compliance with relevant regulation and SOPs
Áö¿øÀÚ°Ý
¤ýÀÇ»ç¼ÒÅë´É·ÂÀÌ ¿øÈ°ÇÑ ÀÚ
¤ý±¹°¡µî·Ï Àå¾ÖÀÎ ¹× ±¹°¡º¸ÈÆ´ë»óÀÚ´Â °ü°è¹ý·É¿¡ µû¶ó ¿ì´ëÇÕ´Ï´Ù.
Á¦Ãâ¼·ù
¿Â¶óÀÎ ÀÔ»çÁö¿ø¼
ÀüÇü¹æ¹ý
¼·ùÀüÇü ¹× ¸éÁ¢
ÀÔ»çÁö¿ø¼ Á¢¼ö±â°£ / Á¦Ãâó / ¹®ÀÇó
1) Á¢¼ö±â°£ 2024-05-07 ºÎÅÍ 2024-05-19 ±îÁö
2) ¹®ÀÇó ¤ýä¿ë´ã´çÀÚ chami.shin@kr.otsuka.com******@*******.*** ¹× ȨÆäÀÌÁö ³» ä¿ëQ&A °Ô½ÃÆÇ
¤ý±¸±Û G-mail·Î ¿ø¼Á¢¼ö ½Ã, Áö¿ø¼ Á¢¼ö ÈÄ ¼öÇè¹øÈ£ ÀÚµ¿ ȸ½Å ¸ÞÀÏÀÌ Á¤»óÀûÀ¸·Î ¼ö½ÅµÇÁö ¾ÊÀ» ¼ö ÀÖ½À´Ï´Ù.
¤ý¼öÇè¹øÈ£ ÀÚµ¿È¸½Å ¸ÞÀÏÀ» ¹ÞÁö ¸øÇϽŠ°æ¿ì, Q&A°Ô½ÃÆÇ ºñ¹Ð±Û ¶Ç´Â ä¿ë´ã´çÀÚ À̸ÞÀÏ·Î ¼ºÇÔ°ú Áö¿øÇϽŠÀ̸ÞÀÏÁÖ¼Ò¸¦ ³²°ÜÁÖ½Ã¸é ¸ÞÀÏ È¸½Å µå¸³´Ï´Ù
3) ¼·ù½É»ç ÇÕ°ÝÀÚ ¹ßÇ¥ 2024-05-23
±âŸ
ä¿ë ÇÁ·Î¼¼½º : ¼·ùÀüÇü¡æ1Â÷(½Ç¹«)¸éÁ¢¡æ2Â÷(ÀÓ¿ø)¸éÁ¢¡æä¿ë°ËÁø¡æÃÖÁ¾ÇÕ°Ý
¼·ùÇÕ°ÝÀÚ´Â °³º°ÀûÀ¸·Î ¿¬¶ôµå¸®¸ç, ¹ßÇ¥ ÀÏÁ¤Àº ȸ»ç »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖ½À´Ï´Ù.